ViaCyte

Diabetes Treatments from Stem Cells

ViaCyte, Inc. is a stem cell engineering company dedicated to creating and commercializing cell therapies to treat diabetes. The company's goal is insulin independence without immunosuppression, hypoglycemia, or other diabetes-related complications.

    

 
Latest News

Aug 9, 2011
ViaCyte Announces Executive Management Changes

June 15, 2011
ViaCyte Names Michael Scott Vice President, Device Research & Development

May 13, 2011
ViaCyte, Inc., Names Anthony Gringeri Chief Development Officer

April 13, 2011
Cellular Dynamics Licenses Technology from ViaCyte

May 5, 2010
Novocell Becomes ViaCyte, Inc. as it Accelerates Pre-clinical Development of a Stem Cell Derived Treatment for Diabetes

May 5, 2010
ViaCyte, Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes

October 28, 2009
Novocell is the Recipient of a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes

Device encapsulated stem cell-derived islet cells. In this image, insulin (INS, blue), glucagon (GCG, red) and somatostatin (SST, green) mark three of the five endocrine cells normally found in human islets.

Home | About Us | Technologies | Clinical Application | Careers | News & Events | Contact | Site Map | Terms of Use

©2010 ViaCyte | 858.455.3708 | info@ViaCyte.com


uggs outletuggs are made of double-faced sheepskin which is snow boots cheap a single layer with the outer as skin and winter coat inner as fleece that maintains the thermostatic nature of sheepskin. cushy foam for extra comfort covered with a north face outlets genuine sheepskin sock that naturally wicks away moisture and puma ferrari shoes helps keep your feet dry.Light and flexible molded EVA bottom with puma outlet a patent protected outsole design for amazing comfort with every step.when you put it on,you will never want to take it off,as it is so warm and comfortable.